Drug Profile
S 488310
Alternative Names: S-488310Latest Information Update: 07 Feb 2014
Price :
$50
*
At a glance
- Originator OncoTherapy Science
- Developer OncoTherapy Science; Shionogi
- Class Cancer vaccines; Peptide vaccines; Peptides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bladder cancer
Most Recent Events
- 05 Feb 2014 Discontinued - Preclinical for Bladder cancer in Japan (Parenteral)
- 03 Feb 2014 Preclinical trials in Bladder cancer in Japan before February 2014 (Parenteral)